ALCON LABS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON LABS INC, and what generic alternatives to ALCON LABS INC drugs are available?
ALCON LABS INC has seventeen approved drugs.
There are forty-one US patents protecting ALCON LABS INC drugs.
There are two hundred and seventeen patent family members on ALCON LABS INC drugs in thirty-one countries and twenty-eight supplementary protection certificates in ten countries.
Summary for ALCON LABS INC
International Patents: | 217 |
US Patents: | 41 |
Tradenames: | 14 |
Ingredients: | 12 |
NDAs: | 17 |
Drugs and US Patents for ALCON LABS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 12,115,246 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 10,058,511 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Alcon Labs Inc | MYDRIACYL | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 084306-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ||||
Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 10,646,436 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 10,688,045 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALCON LABS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 5,116,863*PED | ⤷ Subscribe |
Alcon Labs Inc | SIMBRINZA | brimonidine tartrate; brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 204251-001 | Apr 19, 2013 | 6,316,441 | ⤷ Subscribe |
Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 5,116,863*PED | ⤷ Subscribe |
Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 7,402,609*PED | ⤷ Subscribe |
Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 5,641,805*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALCON LABS INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2016053060 | ⤷ Subscribe |
Brazil | 112014027296 | ⤷ Subscribe |
Japan | 2016535777 | ⤷ Subscribe |
World Intellectual Property Organization (WIPO) | 2013166408 | ⤷ Subscribe |
European Patent Office | 2844295 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ALCON LABS INC Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3053913 | 301038 | Netherlands | ⤷ Subscribe | PRODUCT NAME: NETARSUDIL, OF EEN ZOUT OF SOLVAAAT DAARVAN, IN HET BIJZONDER NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
3043773 | 21C1057 | France | ⤷ Subscribe | PRODUCT NAME: MOMETASONE OU L'UN DE SES SELS AVEC OLOPATADINE OU L'UN DE SES SELS; NAT. REGISTRATION NO/DATE: NL52121 20211026; FIRST REGISTRATION: AT - 140638 20210426 |
3461484 | 2021C/515 | Belgium | ⤷ Subscribe | PRODUCT NAME: ROCLANDA - LATANOPROST / NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/20/1502 20210108 |
3053913 | SPC/GB20/019 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: NETARSUDIL; REGISTERED: UK EU/1/19/1400(NI) 20191121; UK PLGB 16058/003 20191121 |
1631293 | 92462 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.